Perceptions of risk: understanding cardiovascular disease

Ruth Webster, Emma Heeley, Ruth Webster, Emma Heeley

Abstract

Cardiovascular disease (CVD) is still the leading cause of death and disability worldwide despite the availability of well-established and effective preventive options. Accurate perception of a patient's risk by both the patient and the doctors is important as this is one of the components that determine health-related behavior. Doctors tend to not use cardiovascular (CV) risk calculators and underestimate the absolute CV risk of their patients. Patients show optimistic bias when considering their own risk and consistently underestimate it. Poor patient health literacy and numeracy must be considered when thinking about this problem. Patients must possess a reasonably high level of understanding of numerical processes when doctors discuss risk, a level that is not possessed by large numbers of the population. In order to overcome this barrier, doctors need to utilize various tools including the appropriate use of visual aids to accurately communicate risk with their patients. Any intervention has been shown to be better than nothing in improving health understanding. The simple process of repeatedly conveying risk information to a patient has been shown to improve accuracy of risk perception. Doctors need to take responsibility for the accurate assessment and effective communication of CV risk in their patients in order to improve patient uptake of cardioprotective lifestyle choices and preventive medications.

Keywords: cardioprotective lifestyle; cardiovascular disease; risk perception.

References

    1. Murray CJL, Lopez AD. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston, MA: Harvard School of Public Health; 1996.
    1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-HEART study): case-control study. Lancet. 2004;364:937–952.
    1. Sacco RL, Benjamin EJ, Broderick JP, et al. Risk factors. Stroke. 1997;28(7):1507–1517.
    1. Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1 Pt 2):293–298.
    1. Jackson R, Lawes CMM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet. 2005;365(9457):434–441.
    1. British Cardiac S, British Hyperlipidaemia A, British Hypertension S, et al. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. Br Med J. 2000;320(7236):705–708.
    1. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. Br Med J. 2005;320:709–710.
    1. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text: Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil. 2007;14:S1.
    1. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk. 2009. [Accessed July 27, 2010]. Available from: .
    1. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106(3):388–391.
    1. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol. 1997;26(1):1–13.
    1. Parikh P, McDaniel MC, Ashen MD, et al. Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol. 2005;45(9):1379–1387.
    1. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation. 2003;107(24):3109–3116.
    1. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med. 1994;154(2):169–175.
    1. Woodward M, Lam TH, Barzi F, et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005;34(5):1036–1045.
    1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–1278.
    1. Turnbull F Blood Pressure Lowering Treatment Trialists C. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362(9395):1527–1535.
    1. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002;324:71–86.
    1. Mackay J, Mensah G. Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
    1. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk perception and evidence – practice gaps in Australian general practice (the AusHEART study) Med J Aust. 2010;192(5):254–259.
    1. Peiris DP, Patel AA, Cass A, et al. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust. 2009;191(6):304–309.
    1. Webster RJ, Heeley EL, Peiris DP, et al. Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust. 2009;191(6):324–329.
    1. de Koning JS, Klazinga NS, Koudstaal PJ, et al. Quality of care in stroke prevention: results of an audit study among general practitioners. Prev Med. 2004;38(2):129–136.
    1. de Muylder R, Lorant V, Paulus D, et al. Obstacles to cardiovascular prevention in general practice. Acta Cardiol. 2004;59(2):119–125.
    1. Eaton CB, Galliher JM, McBride PE, et al. Family physician’s knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. J Am Board Fam Med. 2006;19(1):46–53.
    1. Graham IM, Stewart M, Hertog MG. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil. 2006;13(5):839–845.
    1. Torley D, Zwar N, Comino EJ, et al. GPs’ views of absolute cardiovascular risk and its role in primary prevention. Aust Fam Physician. 2005;34(6):503–504.
    1. Peeters A, Ting J, Nelson MR, et al. Coronary heart disease risk prediction by general practitioners in Victoria. Med J Aust. 2004;180:252.
    1. Isles CG, Ritchie LD, Murchie P, et al. Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods. Br Med J. 2000;320(7236):690–691.
    1. Cacoub P, Tocque-Le Gousse E, Fabry C, et al. Application in general practice of treatment guidelines for patients with dyslipidaemia: the RESPECT study. Arch Cardiovasc Dis. 2008;101(11–12):715–721.
    1. McManus RJ, Mant J, Meulendijks CFM, et al. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ. 2002;324(7335):459–464.
    1. Montgomery AA, Fahey T, MacKintosh C, et al. Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Pract. 2000;50(451):127–128.
    1. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists’ and cardiologists’ perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med. 1996;124(4):414–421.
    1. Grover SA, Lowensteyn I, Esrey KL, et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ. 1995;310(6985):975–978.
    1. Meland E, Laerum E, Stensvold I. Assessment of coronary heart disease risk, I. A postal inquiry among primary care physicians. Fam Pract. 1994;11(2):117–121.
    1. Pignone M, Phillips CJ, Elasy TA, et al. Physicians’ ability to predict the risk of coronary heart disease. BMC Health Serv Res. 2003;3(1):13.
    1. Thomsen TF, Jørgensen T, Ibsen H, Borch-Johnsen K. Assessment of coronary risk in general practice in relation to the use of guidelines: a survey in Denmark. Prev Med. 2001;33(4):300–304.
    1. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499–510.
    1. Mosca L, Mochari-Greenberger H, Dolor RJ, et al. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3(2):120–127.
    1. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA. 1998;279(16):1288–1292.
    1. Ritchie JE, Herscovitch F, Norfor JB. Beliefs of blue collar workers regarding coronary risk behaviours. Health Educ Res. 1994;9(1):95–103.
    1. Knox SA, Harrison CM, Britt HC, et al. Estimating prevalence of common chronic morbidities in Australia. Med J Aust. 2008;189(2):66–70.
    1. Doroodchi H, Abdolrasulnia M, Foster J, et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract. 2008;9(1):42.
    1. van Steenkiste B, van der Weijden T, Stoffers HEJH, et al. Barriers to implementing cardiovascular risk tables in routine general practice. Scand J Prim Health Care. 2004;22(1):32–37.
    1. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11(1):1–47.
    1. Prentice-Dunn S, Rogers RW. Protection motivation theory and preventive health: beyond the health belief model. Health Educ Res. 1986;1(3):153–161.
    1. Loewenstein GF, Weber EU, Hsee CK, et al. Risk as feelings. Psychol Bull. 2001;127(2):267–286.
    1. Slovic P, Finucane ML, Peters E, et al. Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal. 2004;24(2):311–322.
    1. Weinstein ND. Unrealistic optimism about susceptibility to health problems. J Behav Med. 1982;5(4):441–460.
    1. Weinstein ND. Why it won’t happen to me: perceptions of risk factors and susceptibility. Health Psychol. 1984;3(5):431–457.
    1. Weinstein ND. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987;10(5):481–500.
    1. Avis NE, Smith KW, McKinlay JB. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? Am J Public Health. 1989;79(12):1608–1612.
    1. Marteau TM, Kinmonth AL, Pyke S, et al. Readiness for lifestyle advice: self-assessments of coronary risk prior to screening in the British family heart study. Family Heart Study Group. Br J Gen Pract. 1995;45(390):5–8.
    1. Niknian M, McKinlay SM, Rakowski W, et al. A comparison of perceived and objective CVD risk in a general population. Am J Public Health. 1989;79(12):1653–1654.
    1. van der Weijden T, van Steenkiste B, Stoffers HE, Timmermans DR, Grol R. Primary prevention of cardiovascular diseases in general practice: mismatch between cardiovascular risk and patients’ risk perceptions. Med Decis Making. 2007;27(6):754–761.
    1. Christian AH, Mochari HY, Mosca LJ. Coronary heart disease in ethnically diverse women: risk perception and communication. Mayo Clin Proc. 2005;80(12):1593–1599.
    1. Frijling BD, Lobo CM, Keus IM, et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns. 2004;52(1):47–53.
    1. Christian AH, Rosamond W, White AR, et al. Nine-year trends and racial and ethnic disparities in women’s awareness of heart disease and stroke: an American Heart Association national study. J Womens Health. 2007;16(1):68–81.
    1. Mosca L, Ferris A, Fabunmi R, et al. Tracking women’s awareness of heart disease: an American Heart Association national study. Circulation. 2004;109(5):573–579.
    1. Mosca L, Jones WK, King KB, et al. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women’s Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000;9(6):506–515.
    1. Robertson RM. Women and cardiovascular disease: the risks of misperception and the need for action. Circulation. 2001;103(19):2318–2320.
    1. Furze G, Lewin B. Causal attributions for angina: results of an interview study. Coronary Health Care. 2000;4(3):130–134.
    1. Hart PL. Women’s perceptions of coronary heart disease: an integrative review. J Cardiovasc Nurs. 2005;20(3):170–176.
    1. Samsa GP, Cohen SJ, Goldstein LB, et al. Knowledge of risk among patients at increased risk for stroke. Stroke. 1997;28(5):916–921.
    1. Broadbent E, Petrie KJ, Ellis CJ, et al. Patients with acute myocardial infarction have an inaccurate understanding of their risk of a future cardiac event. Intern Med J. 2006;36(10):643–647.
    1. Carroll C, Naylor E, Marsden P, et al. How do people with Type 2 diabetes perceive and respond to cardiovascular risk? Diabet Med. 2003;20(5):355–360.
    1. Strecher VJ, Kreuter MW, Kobrin SC. Do cigarette smokers have unrealistic perceptions of their heart attack, cancer, and stroke risks? J Behav Med. 1995;18(1):45–54.
    1. Goldman RE, Parker DR, Eaton CB, et al. Patients’ perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006;4(3):205.
    1. Meischke H, Sellers DE, Robbins ML, et al. Factors that influence personal perceptions of the risk of an acute myocardial infarction. Behav Med. 2000;26(1):4–13.
    1. Silagy C, Muir J, Coulter A, et al. Cardiovascular risk and attitudes to lifestyle: what do patients think?[see comment] BMJ. 1993;306(6893):1657–1560.
    1. Hunt K, Davison C, Emslie C, et al. Are perceptions of a family history of heart disease related to health-related attitudes and behaviour? Health Educ Res. 2000;15(2):131–143.
    1. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs AMA. Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA. 1999;281(6):552–557.
    1. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15(3):259–267.
    1. Reyna VF, Nelson WL, Han PK, et al. How numeracy influences risk comprehension and medical decision making. Psychol Bull. 2009;135(6):943–973.
    1. Eichler K, Wieser S, Brugger U. The costs of limited health literacy: a systematic review. Int J Public Health. 2009;54(5):313–324.
    1. Nelson W, Reyna VF, Fagerlin A, et al. Clinical implications of numeracy: theory and practice. Ann Behav Med. 2008;35(3):261–274.
    1. Safeer RS, Cooke CE, Keenan J. The impact of health literacy on cardiovascular disease. Vasc Health Risk Manag. 2006;2(4):457–464.
    1. Covey J. A Meta-analysis of the effects of presenting treatment benefits in different formats. Med Decis Making. 2007;27(5):638–654.
    1. Edwards A, Elwyn G, Covey J, et al. Presenting risk information – a review of the effects of framing and other manipulations on patient outcomes. J Health Commun. 2001;6(1):61–82.
    1. Moxey A, O’Connell D, McGettigan P, et al. Describing treatment effects to patients. J Gen Intern Med. 2003;18(11):948–959.
    1. McGettigan P, Sly K, O’Connell D, et al. The effects of information framing on the practices of physicians. JGIM. 1999;14:633–642.
    1. Witte K, Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav. 2000;27(5):591–615.
    1. Trevena LJ, Davey HM, Barratt A, et al. A systematic review on communicating with patients about evidence. J Eval Clin Pract. 2006;12(1):13–23.
    1. O’Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3):CD001431.
    1. Sheridan SL, Viera AJ, Krantz MJ, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010;170(3):230–239.
    1. Lipkus IM. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making. 2007;27(5):696–713.
    1. Paling J. Strategies to help patients understand risks. BMJ. 2003;327(7417):745–748.
    1. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327:741–744.
    1. Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? BMJ. 2003;327(7417):728–731.
    1. Woloshin S, Schwartz LM, Welch HG. The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations. Ann Intern Med. 2007;146(4):256–265.
    1. Fortin J, Hirota L, Bond B, et al. Identifying patient preferences for communicating risk estimates: a descriptive pilot study. BMC Med Inform Decis Mak. 2001;1(1):2.
    1. Portnoy DB, Scott-Sheldon LAJ, Johnson BT, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47(1):3–16.
    1. Burns E. Active Home Internet Users by Country. Sep, 2008. [Accessed February 18, 2010]. Available from: . Archived at: .
    1. Fox S. Online Health Search. 2006. [Accessed February 18, 2010]. Available from: . Archived at: .
    1. Murray E, Burns J, See TS, et al. Interactive Health Communication Applications for people with chronic disease. Cochrane Database Syst Rev. 2005;(4):CD004274. Update of Cochrane Database Syst Rev. 2004;(4):CD004274.
    1. Kroeze W, Werkman A, Brug J. A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006;31(3):205–223.
    1. Kreuter MW, Strecher VJ. Do tailored behavior change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial. Health Educ Res. 1996;11(1):97–105.
    1. Bennet M. A risk score for cardiovascular disease. 2005. [Accessed February 18, 2010]. Available from: . Archived at: .
    1. Siteman Cancer Center. Your Disease Risk: the source on prevention. [Accessed February 18, 2010]. Available from: . Archived at: .
    1. Peiris DP, Joshi R, Webster RJ, et al. An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation. J Med Internet Res. 2009;11(4):e51.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi